Valeant to Buy Salix for About $10 Billion

Valeant Pharmaceuticals said Sunday it would buy Salix Pharmaceuticals for about $10 billion, a return to its big deal-making ways after a failed bid for Botox maker Allergan Inc. last year.



via WSJ.com: Markets http://ift.tt/1JBo3hS